Yesterday, Johnson & Johnson Medical Technology announced that its subsidiaryInhance Intact Shoulder Arthroplasty Instrument System Officially Launches in the U.S. Market. This system, specifically designed for total shoulder arthroplasty (TSA) with subscapularis preservation, is rewriting the rehabilitation rules for shoulder surgeries with breakthrough technology.

Inhance Intact System

TraditionalTSA surgery requires the detachment of the subscapularis tendon, leading to a postoperative immobilization period of up to six weeks for patients. In contrast, the Inhance Intact system, through the combination of 43 dedicated instruments and the TruMatch 3D preoperative planning cloud system, enables the complete preservation of the subscapularis. According to Johnson & Johnson data, its tissue-preserving technology allows patients to move their shoulders within one day after surgery, making it an ideal choice for Ambulatory Surgery Centers (ASC).

President of Johnson & Johnson Medical Technology Company, Global ReconstructionSharrolyn Josse said:“The launch of Inhance Intact marks an important step forward in advancing shoulder care through thoughtful, clinically-driven innovation.“By providing solutions for surgeons that enable patients to mobilize immediately, we are expanding the possibilities for surgeons and reinforcing an approach aimed at improving outcomes, accelerating recovery, and supporting the shift toward outpatient care.”

2025 Orthopedic New Product Matrix

Covering Joints, Trauma, and Surgical Automation

Inhance Intact is just a microcosm of Johnson & Johnson's orthopedic innovations this year, with multiple new products building up a full-scenario solution:

Kincise 2 Surgical Automatic Electric Tool System（June Launch): This product aims to improve the efficiency of various surgeries, providing surgeons with more precise control while effectively reducing their physical burden. Kincise 2 offers an acetabular cup extraction function, making it the first and only automated impactor approved for the removal of well-fixed acetabular components.

VOLT Series Bone Plate System（June 19）：Johnson & Johnson announces the launch of two newVOLT（Variable Angle Optimization Locking Technology）Plate System, respectivelyVOLT Distal Radius (Wrist) Plate System and VOLT Proximal Humerus 3.5 Plate System. These two innovative products fill a critical gap in the treatment of two common fractures, providing orthopedic surgeons with more advanced surgical solutions.

AIDriven Orthopedic Surgery System（July 29）：Johnson & Johnson Medical officially released a product named VIRTUGUIDE™ AI-Driven Orthopedic Surgery System. This system is positioned in orthopedic surgery forCorrection of Hallux Valgus Deformity(i.e.Hallux Valgus corrective surgery, also known as the Lapidus procedure, utilizes AI technology for preoperative planning to create personalized correction plans for each patient.

In the global orthopedicsIn the competition of a $740 billion market (forecast for 2027), Johnson & Johnson is“Tissue Preservation + Automation + AI” A combination of technologies that redefine the standards of surgical procedures.